肝细胞癌中趋化因子样因子样 MARVEL 跨膜结构域家族：最新进展
Chemokine-Like Factor-Like MARVEL Transmembrane Domain-Containing Family in Hepatocellular Carcinoma: Latest Advances.
作者信息
Li Mengxia, Luo Fangzhou, Tian Xinyao, Yin Shengyong, Zhou Lin, Zheng Shusen
机构信息
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
School of Medicine, Zhejiang University, Hangzhou, China.
出版信息
Front Oncol. 2020 Nov 13;10:595973. doi: 10.3389/fonc.2020.595973. eCollection 2020.
Abstract
Chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTMs) is a new gene family, consisting of CKLF and CMTM1 to CMTM8, which plays an important role in hematopoiesis system, autoimmune diseases, male reproduction etc. Abnormal expression of CMTMs is also associated with tumor genesis, development and metastasis. In this review, we briefly describe the characteristics of CMTM family, outline its functions in multiple kinds of carcinomas, and summarize the latest research on their roles in hepatocellular carcinoma which are mainly related to the expression, prognostic effect, potential functions, and mechanism of action. The CMTM family is expected to provide new ideas and targets for HCC diagnosis and treatment.
摘要
趋化因子样因子（CKLF）样含MARVEL跨膜结构域家族（CMTMs）是一个新的基因家族，由CKLF以及CMTM1至CMTM8组成，在造血系统、自身免疫性疾病、男性生殖等方面发挥重要作用。CMTMs的异常表达也与肿瘤的发生、发展和转移有关。在本综述中，我们简要描述了CMTM家族的特征，概述了其在多种癌症中的功能，并总结了其在肝细胞癌中作用的最新研究，这些研究主要涉及表达、预后影响、潜在功能和作用机制。CMTM家族有望为肝癌的诊断和治疗提供新的思路和靶点。
相似文献
1
Chemokine-Like Factor-Like MARVEL Transmembrane Domain-Containing Family in Hepatocellular Carcinoma: Latest Advances.
Front Oncol. 2020 Nov 13;10:595973. doi: 10.3389/fonc.2020.595973. eCollection 2020.
2
Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
Int J Biol Sci. 2019 Sep 7;15(12):2576-2583. doi: 10.7150/ijbs.33733. eCollection 2019.
3
Cancer Research Advance in CKLF-like MARVEL Transmembrane Domain Containing Member Family (Review).
Asian Pac J Cancer Prev. 2016;17(6):2741-4.
4
Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma.
J Hepatocell Carcinoma. 2023 Aug 25;10:1411-1422. doi: 10.2147/JHC.S417202. eCollection 2023.
5
CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive Review.
Cancer Manag Res. 2022 Apr 26;14:1551-1563. doi: 10.2147/CMAR.S358963. eCollection 2022.
6
as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma.
Curr Oncol. 2023 Feb 22;30(3):2653-2672. doi: 10.3390/curroncol30030202.
7
Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.
PeerJ. 2024 Jan 10;12:e16757. doi: 10.7717/peerj.16757. eCollection 2024.
8
Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases.
Chin Med J (Engl). 2020 Apr 20;133(8):951-958. doi: 10.1097/CM9.0000000000000747.
9
[Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors].
Zhongguo Fei Ai Za Zhi. 2023 Jan 20;26(1):46-51. doi: 10.3779/j.issn.1009-3419.2023.106.01.
10
CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.
Cancer Biol Med. 2020 Aug 15;17(3):528-542. doi: 10.20892/j.issn.2095-3941.2020.0032.
引用本文的文献
1
Comprehensive analysis of CMTM family and immune infiltration in esophageal carcinoma.
PLoS One. 2025 Apr 3;20(4):e0321037. doi: 10.1371/journal.pone.0321037. eCollection 2025.
2
Shared Genes and Pathways in Ulcerative Colitis and Ankylosing Spondylitis: Functional Validation and Implications for Diagnosis.
J Inflamm Res. 2025 Feb 4;18:1657-1678. doi: 10.2147/JIR.S497201. eCollection 2025.
3
Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.
PeerJ. 2024 Jan 10;12:e16757. doi: 10.7717/peerj.16757. eCollection 2024.
4
Nomogram based on CMTM6 expression and clinical characteristics to predict postoperative overall survival in patients with hepatocellular carcinoma.
Histol Histopathol. 2024 Mar;39(3):381-390. doi: 10.14670/HH-18-643. Epub 2023 Jun 19.
5
Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations.
World J Stem Cells. 2023 May 26;15(5):302-322. doi: 10.4252/wjsc.v15.i5.302.
6
as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma.
Curr Oncol. 2023 Feb 22;30(3):2653-2672. doi: 10.3390/curroncol30030202.
7
CMTM6 and CMTM7: New leads for PD-L1 regulation in breast cancer cells undergoing EMT.
J Cell Biochem. 2022 Jun;123(6):1025-1031. doi: 10.1002/jcb.30273. Epub 2022 May 16.
8
CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive Review.
Cancer Manag Res. 2022 Apr 26;14:1551-1563. doi: 10.2147/CMAR.S358963. eCollection 2022.
9
CMTM6 as a master regulator of PD-L1.
Cancer Immunol Immunother. 2022 Oct;71(10):2325-2340. doi: 10.1007/s00262-022-03171-y. Epub 2022 Mar 16.
10
CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways.
Front Cell Dev Biol. 2022 Feb 17;10:740822. doi: 10.3389/fcell.2022.740822. eCollection 2022.
本文引用的文献
1
CMTM family proteins 1-8: roles in cancer biological processes and potential clinical value.
Cancer Biol Med. 2020 Aug 15;17(3):528-542. doi: 10.20892/j.issn.2095-3941.2020.0032.
2
Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma.
Cancer Immunol Immunother. 2021 Feb;70(2):417-429. doi: 10.1007/s00262-020-02691-9. Epub 2020 Aug 7.
3
Chemokine-like factor 1: A promising therapeutic target in human diseases.
Exp Biol Med (Maywood). 2020 Oct;245(16):1518-1528. doi: 10.1177/1535370220945225. Epub 2020 Jul 26.
4
CMTM6 promotes cell proliferation and invasion in oral squamous cell carcinoma by interacting with NRP1.
Am J Cancer Res. 2020 Jun 1;10(6):1691-1709. eCollection 2020.
5
Down-Regulated CMTM2 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
Onco Targets Ther. 2020 Jun 17;13:5731-5741. doi: 10.2147/OTT.S250370. eCollection 2020.
6
Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway.
Cancer Lett. 2020 Oct 10;490:20-30. doi: 10.1016/j.canlet.2020.06.009. Epub 2020 Jun 23.
7
CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
Cancer Biomark. 2020;29(1):89-99. doi: 10.3233/CBM-191226.
8
Increased CMTM4 mRNA expression predicts a poor prognosis in patients with hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 2020 Dec;19(6):596-601. doi: 10.1016/j.hbpd.2020.06.004. Epub 2020 Jun 12.
9
CMTM5-v1 inhibits cell proliferation and migration by downregulating oncogenic EGFR signaling in prostate cancer cells.
J Cancer. 2020 Apr 6;11(13):3762-3770. doi: 10.7150/jca.42314. eCollection 2020.
10
Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression.
Int Immunopharmacol. 2020 Jun;83:106478. doi: 10.1016/j.intimp.2020.106478. Epub 2020 Apr 8.
Zotero 插件